University at Buffalo - The State University of New York
Skip to Content
UBMD Physicians' Group

Clinical Trials

An International, Multicenter, Prospective Observational Study of the Safety of Maraviroc used with Optimized Background Therapy in Treatment -Experienced HIV-1 Infected Patient.

Prospective Observational Epidemiologic Study of Maraviroc's Safety

This study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.

Eligibility

Treatment experienced, HIV-1 infected patients; 18 years or older; Receive an approved assay for determination of HIV-1 tropism

Investigator

Alyssa Shon, MD

Contact Information

Name: Alyssa Shon, MD
Phone: 898-4119
Email: alyssash@buffalo.edu